nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—ABCC10—Methotrexate—psoriatic arthritis	0.11	0.137	CbGbCtD
Etoposide—PTGS2—Triamcinolone—psoriatic arthritis	0.0777	0.0963	CbGbCtD
Etoposide—ABCC3—Methotrexate—psoriatic arthritis	0.0694	0.086	CbGbCtD
Etoposide—PTGS2—Betamethasone—psoriatic arthritis	0.0667	0.0826	CbGbCtD
Etoposide—ABCC1—Methotrexate—psoriatic arthritis	0.0426	0.0528	CbGbCtD
Etoposide—ABCC2—Dexamethasone—psoriatic arthritis	0.0392	0.0486	CbGbCtD
Etoposide—PTGS2—Dexamethasone—psoriatic arthritis	0.0388	0.0481	CbGbCtD
Etoposide—ABCG2—Dexamethasone—psoriatic arthritis	0.0355	0.044	CbGbCtD
Etoposide—ABCB1—Methylprednisolone—psoriatic arthritis	0.0338	0.0419	CbGbCtD
Etoposide—ABCC2—Methotrexate—psoriatic arthritis	0.0315	0.0391	CbGbCtD
Etoposide—ABCG2—Methotrexate—psoriatic arthritis	0.0285	0.0353	CbGbCtD
Etoposide—CYP2E1—Dexamethasone—psoriatic arthritis	0.0253	0.0313	CbGbCtD
Etoposide—ABCB1—Betamethasone—psoriatic arthritis	0.022	0.0273	CbGbCtD
Etoposide—ABCB1—Prednisolone—psoriatic arthritis	0.0217	0.0269	CbGbCtD
Etoposide—ABCB1—Prednisone—psoriatic arthritis	0.0205	0.0254	CbGbCtD
Etoposide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0203	0.0251	CbGbCtD
Etoposide—CYP3A5—Dexamethasone—psoriatic arthritis	0.0197	0.0244	CbGbCtD
Etoposide—CYP2C8—Dexamethasone—psoriatic arthritis	0.0189	0.0234	CbGbCtD
Etoposide—CYP3A4—Triamcinolone—psoriatic arthritis	0.0154	0.019	CbGbCtD
Etoposide—CYP3A4—Betamethasone—psoriatic arthritis	0.0132	0.0163	CbGbCtD
Etoposide—CYP3A4—Prednisolone—psoriatic arthritis	0.013	0.0161	CbGbCtD
Etoposide—ABCB1—Dexamethasone—psoriatic arthritis	0.0128	0.0159	CbGbCtD
Etoposide—CYP3A4—Prednisone—psoriatic arthritis	0.0123	0.0152	CbGbCtD
Etoposide—ABCB1—Methotrexate—psoriatic arthritis	0.0103	0.0127	CbGbCtD
Etoposide—CYP3A4—Dexamethasone—psoriatic arthritis	0.00766	0.0095	CbGbCtD
Etoposide—PTGS2—Fluocinonide—Methylprednisolone—psoriatic arthritis	0.00081	0.148	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Betamethasone—psoriatic arthritis	0.000798	0.145	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Dexamethasone—psoriatic arthritis	0.000798	0.145	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Triamcinolone—psoriatic arthritis	0.000779	0.142	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.000489	0.0892	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.000481	0.0878	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.000481	0.0878	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.00047	0.0858	CbGdCrCtD
Etoposide—Eye disorder—Dexamethasone—psoriatic arthritis	0.000317	0.00169	CcSEcCtD
Etoposide—Eye disorder—Betamethasone—psoriatic arthritis	0.000317	0.00169	CcSEcCtD
Etoposide—Back pain—Triamcinolone—psoriatic arthritis	0.000315	0.00168	CcSEcCtD
Etoposide—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000311	0.00166	CcSEcCtD
Etoposide—Angiopathy—Betamethasone—psoriatic arthritis	0.000308	0.00164	CcSEcCtD
Etoposide—Angiopathy—Dexamethasone—psoriatic arthritis	0.000308	0.00164	CcSEcCtD
Etoposide—Convulsion—Prednisolone—psoriatic arthritis	0.000307	0.00163	CcSEcCtD
Etoposide—Hypertension—Prednisolone—psoriatic arthritis	0.000306	0.00163	CcSEcCtD
Etoposide—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000302	0.00161	CcSEcCtD
Etoposide—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000301	0.00161	CcSEcCtD
Etoposide—Alopecia—Betamethasone—psoriatic arthritis	0.0003	0.0016	CcSEcCtD
Etoposide—Alopecia—Dexamethasone—psoriatic arthritis	0.0003	0.0016	CcSEcCtD
Etoposide—Discomfort—Prednisolone—psoriatic arthritis	0.000298	0.00159	CcSEcCtD
Etoposide—Malaise—Triamcinolone—psoriatic arthritis	0.000294	0.00156	CcSEcCtD
Etoposide—Pancytopenia—Methotrexate—psoriatic arthritis	0.000293	0.00156	CcSEcCtD
Etoposide—Malaise—Methylprednisolone—psoriatic arthritis	0.000293	0.00156	CcSEcCtD
Etoposide—Vertigo—Triamcinolone—psoriatic arthritis	0.000293	0.00156	CcSEcCtD
Etoposide—Vertigo—Methylprednisolone—psoriatic arthritis	0.000292	0.00156	CcSEcCtD
Etoposide—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000289	0.00154	CcSEcCtD
Etoposide—Neutropenia—Methotrexate—psoriatic arthritis	0.000289	0.00154	CcSEcCtD
Etoposide—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000286	0.00153	CcSEcCtD
Etoposide—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000286	0.00152	CcSEcCtD
Etoposide—Cough—Triamcinolone—psoriatic arthritis	0.000284	0.00151	CcSEcCtD
Etoposide—Convulsion—Triamcinolone—psoriatic arthritis	0.000282	0.0015	CcSEcCtD
Etoposide—Tachycardia—Prednisolone—psoriatic arthritis	0.000282	0.0015	CcSEcCtD
Etoposide—Convulsion—Methylprednisolone—psoriatic arthritis	0.000281	0.0015	CcSEcCtD
Etoposide—Hypertension—Triamcinolone—psoriatic arthritis	0.000281	0.0015	CcSEcCtD
Etoposide—Hypertension—Methylprednisolone—psoriatic arthritis	0.00028	0.00149	CcSEcCtD
Etoposide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000279	0.00149	CcSEcCtD
Etoposide—Pneumonia—Methotrexate—psoriatic arthritis	0.000277	0.00147	CcSEcCtD
Etoposide—Eye disorder—Prednisone—psoriatic arthritis	0.000276	0.00147	CcSEcCtD
Etoposide—Infestation NOS—Methotrexate—psoriatic arthritis	0.000275	0.00147	CcSEcCtD
Etoposide—Infestation—Methotrexate—psoriatic arthritis	0.000275	0.00147	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000275	0.00146	CcSEcCtD
Etoposide—Flushing—Prednisone—psoriatic arthritis	0.000274	0.00146	CcSEcCtD
Etoposide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000274	0.00146	CcSEcCtD
Etoposide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000274	0.00146	CcSEcCtD
Etoposide—Discomfort—Triamcinolone—psoriatic arthritis	0.000274	0.00146	CcSEcCtD
Etoposide—Discomfort—Methylprednisolone—psoriatic arthritis	0.000273	0.00146	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000273	0.00145	CcSEcCtD
Etoposide—Renal failure—Methotrexate—psoriatic arthritis	0.00027	0.00144	CcSEcCtD
Etoposide—Stomatitis—Methotrexate—psoriatic arthritis	0.000268	0.00143	CcSEcCtD
Etoposide—Angiopathy—Prednisone—psoriatic arthritis	0.000268	0.00143	CcSEcCtD
Etoposide—Confusional state—Methylprednisolone—psoriatic arthritis	0.000267	0.00142	CcSEcCtD
Etoposide—Immune system disorder—Prednisone—psoriatic arthritis	0.000267	0.00142	CcSEcCtD
Etoposide—Malaise—Dexamethasone—psoriatic arthritis	0.000266	0.00142	CcSEcCtD
Etoposide—Malaise—Betamethasone—psoriatic arthritis	0.000266	0.00142	CcSEcCtD
Etoposide—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000266	0.00142	CcSEcCtD
Etoposide—Vertigo—Betamethasone—psoriatic arthritis	0.000265	0.00141	CcSEcCtD
Etoposide—Vertigo—Dexamethasone—psoriatic arthritis	0.000265	0.00141	CcSEcCtD
Etoposide—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000265	0.00141	CcSEcCtD
Etoposide—Infection—Triamcinolone—psoriatic arthritis	0.000264	0.00141	CcSEcCtD
Etoposide—Infection—Methylprednisolone—psoriatic arthritis	0.000263	0.0014	CcSEcCtD
Etoposide—Alopecia—Prednisone—psoriatic arthritis	0.000261	0.00139	CcSEcCtD
Etoposide—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00026	0.00139	CcSEcCtD
Etoposide—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00026	0.00138	CcSEcCtD
Etoposide—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00026	0.00138	CcSEcCtD
Etoposide—Paraesthesia—Prednisolone—psoriatic arthritis	0.000259	0.00138	CcSEcCtD
Etoposide—Tachycardia—Triamcinolone—psoriatic arthritis	0.000259	0.00138	CcSEcCtD
Etoposide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000259	0.00138	CcSEcCtD
Etoposide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000258	0.00137	CcSEcCtD
Etoposide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000257	0.00137	CcSEcCtD
Etoposide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000257	0.00137	CcSEcCtD
Etoposide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000256	0.00137	CcSEcCtD
Etoposide—Convulsion—Dexamethasone—psoriatic arthritis	0.000256	0.00136	CcSEcCtD
Etoposide—Convulsion—Betamethasone—psoriatic arthritis	0.000256	0.00136	CcSEcCtD
Etoposide—Hypertension—Betamethasone—psoriatic arthritis	0.000255	0.00136	CcSEcCtD
Etoposide—Hypertension—Dexamethasone—psoriatic arthritis	0.000255	0.00136	CcSEcCtD
Etoposide—Discomfort—Betamethasone—psoriatic arthritis	0.000248	0.00132	CcSEcCtD
Etoposide—Discomfort—Dexamethasone—psoriatic arthritis	0.000248	0.00132	CcSEcCtD
Etoposide—Hypotension—Methylprednisolone—psoriatic arthritis	0.000248	0.00132	CcSEcCtD
Etoposide—Pain—Prednisolone—psoriatic arthritis	0.000247	0.00132	CcSEcCtD
Etoposide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000244	0.0013	CcSEcCtD
Etoposide—Urethral disorder—Methotrexate—psoriatic arthritis	0.000242	0.00129	CcSEcCtD
Etoposide—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000241	0.00129	CcSEcCtD
Etoposide—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000241	0.00129	CcSEcCtD
Etoposide—Infection—Dexamethasone—psoriatic arthritis	0.00024	0.00128	CcSEcCtD
Etoposide—Infection—Betamethasone—psoriatic arthritis	0.00024	0.00128	CcSEcCtD
Etoposide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000239	0.00127	CcSEcCtD
Etoposide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000239	0.00127	CcSEcCtD
Etoposide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000238	0.00127	CcSEcCtD
Etoposide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000238	0.00127	CcSEcCtD
Etoposide—Anaemia—Prednisone—psoriatic arthritis	0.000238	0.00127	CcSEcCtD
Etoposide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000237	0.00126	CcSEcCtD
Etoposide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000236	0.00126	CcSEcCtD
Etoposide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000236	0.00126	CcSEcCtD
Etoposide—Tachycardia—Dexamethasone—psoriatic arthritis	0.000235	0.00125	CcSEcCtD
Etoposide—Tachycardia—Betamethasone—psoriatic arthritis	0.000235	0.00125	CcSEcCtD
Etoposide—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000234	0.00124	CcSEcCtD
Etoposide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000233	0.00124	CcSEcCtD
Etoposide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000233	0.00124	CcSEcCtD
Etoposide—Malaise—Prednisone—psoriatic arthritis	0.000232	0.00124	CcSEcCtD
Etoposide—Vertigo—Prednisone—psoriatic arthritis	0.000231	0.00123	CcSEcCtD
Etoposide—Eye disorder—Methotrexate—psoriatic arthritis	0.000231	0.00123	CcSEcCtD
Etoposide—Anorexia—Betamethasone—psoriatic arthritis	0.00023	0.00122	CcSEcCtD
Etoposide—Anorexia—Dexamethasone—psoriatic arthritis	0.00023	0.00122	CcSEcCtD
Etoposide—Urticaria—Prednisolone—psoriatic arthritis	0.00023	0.00122	CcSEcCtD
Etoposide—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000229	0.00122	CcSEcCtD
Etoposide—Fatigue—Triamcinolone—psoriatic arthritis	0.000229	0.00122	CcSEcCtD
Etoposide—Fatigue—Methylprednisolone—psoriatic arthritis	0.000229	0.00122	CcSEcCtD
Etoposide—Pain—Triamcinolone—psoriatic arthritis	0.000227	0.00121	CcSEcCtD
Etoposide—Loss of consciousness—Prednisone—psoriatic arthritis	0.000226	0.00121	CcSEcCtD
Etoposide—Hypotension—Betamethasone—psoriatic arthritis	0.000225	0.0012	CcSEcCtD
Etoposide—Hypotension—Dexamethasone—psoriatic arthritis	0.000225	0.0012	CcSEcCtD
Etoposide—Angiopathy—Methotrexate—psoriatic arthritis	0.000224	0.00119	CcSEcCtD
Etoposide—Immune system disorder—Methotrexate—psoriatic arthritis	0.000223	0.00119	CcSEcCtD
Etoposide—Convulsion—Prednisone—psoriatic arthritis	0.000223	0.00119	CcSEcCtD
Etoposide—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000223	0.00119	CcSEcCtD
Etoposide—Hypertension—Prednisone—psoriatic arthritis	0.000222	0.00118	CcSEcCtD
Etoposide—Chills—Methotrexate—psoriatic arthritis	0.000222	0.00118	CcSEcCtD
Etoposide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000219	0.00117	CcSEcCtD
Etoposide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000218	0.00116	CcSEcCtD
Etoposide—Alopecia—Methotrexate—psoriatic arthritis	0.000218	0.00116	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000218	0.00116	CcSEcCtD
Etoposide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000217	0.00116	CcSEcCtD
Etoposide—Paraesthesia—Betamethasone—psoriatic arthritis	0.000216	0.00115	CcSEcCtD
Etoposide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000216	0.00115	CcSEcCtD
Etoposide—Discomfort—Prednisone—psoriatic arthritis	0.000216	0.00115	CcSEcCtD
Etoposide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000213	0.00113	CcSEcCtD
Etoposide—Urticaria—Triamcinolone—psoriatic arthritis	0.000211	0.00113	CcSEcCtD
Etoposide—Urticaria—Methylprednisolone—psoriatic arthritis	0.000211	0.00112	CcSEcCtD
Etoposide—Dysgeusia—Methotrexate—psoriatic arthritis	0.000211	0.00112	CcSEcCtD
Etoposide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00021	0.00112	CcSEcCtD
Etoposide—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00021	0.00112	CcSEcCtD
Etoposide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00021	0.00112	CcSEcCtD
Etoposide—Decreased appetite—Betamethasone—psoriatic arthritis	0.00021	0.00112	CcSEcCtD
Etoposide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00021	0.00112	CcSEcCtD
Etoposide—Infection—Prednisone—psoriatic arthritis	0.000209	0.00111	CcSEcCtD
Etoposide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000208	0.00111	CcSEcCtD
Etoposide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000208	0.00111	CcSEcCtD
Etoposide—Back pain—Methotrexate—psoriatic arthritis	0.000208	0.00111	CcSEcCtD
Etoposide—Fatigue—Betamethasone—psoriatic arthritis	0.000208	0.00111	CcSEcCtD
Etoposide—Fatigue—Dexamethasone—psoriatic arthritis	0.000208	0.00111	CcSEcCtD
Etoposide—Pain—Dexamethasone—psoriatic arthritis	0.000206	0.0011	CcSEcCtD
Etoposide—Pain—Betamethasone—psoriatic arthritis	0.000206	0.0011	CcSEcCtD
Etoposide—Tachycardia—Prednisone—psoriatic arthritis	0.000205	0.00109	CcSEcCtD
Etoposide—Skin disorder—Prednisone—psoriatic arthritis	0.000204	0.00109	CcSEcCtD
Etoposide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000203	0.00108	CcSEcCtD
Etoposide—Anorexia—Prednisone—psoriatic arthritis	0.0002	0.00107	CcSEcCtD
Etoposide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000199	0.00106	CcSEcCtD
Etoposide—Anaemia—Methotrexate—psoriatic arthritis	0.000199	0.00106	CcSEcCtD
Etoposide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000199	0.00106	CcSEcCtD
Etoposide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000199	0.00106	CcSEcCtD
Etoposide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000197	0.00105	CcSEcCtD
Etoposide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000197	0.00105	CcSEcCtD
Etoposide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000196	0.00104	CcSEcCtD
Etoposide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000195	0.00104	CcSEcCtD
Etoposide—Malaise—Methotrexate—psoriatic arthritis	0.000194	0.00103	CcSEcCtD
Etoposide—Vertigo—Methotrexate—psoriatic arthritis	0.000193	0.00103	CcSEcCtD
Etoposide—Leukopenia—Methotrexate—psoriatic arthritis	0.000192	0.00103	CcSEcCtD
Etoposide—Urticaria—Dexamethasone—psoriatic arthritis	0.000192	0.00102	CcSEcCtD
Etoposide—Urticaria—Betamethasone—psoriatic arthritis	0.000192	0.00102	CcSEcCtD
Etoposide—TOP2A—Methyltestosterone—Prednisone—psoriatic arthritis	0.000191	0.0349	CbGdCrCtD
Etoposide—Dizziness—Prednisolone—psoriatic arthritis	0.000191	0.00102	CcSEcCtD
Etoposide—Asthenia—Triamcinolone—psoriatic arthritis	0.000191	0.00102	CcSEcCtD
Etoposide—Abdominal pain—Betamethasone—psoriatic arthritis	0.000191	0.00102	CcSEcCtD
Etoposide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000191	0.00102	CcSEcCtD
Etoposide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000191	0.00102	CcSEcCtD
Etoposide—Body temperature increased—Betamethasone—psoriatic arthritis	0.000191	0.00102	CcSEcCtD
Etoposide—Asthenia—Methylprednisolone—psoriatic arthritis	0.00019	0.00101	CcSEcCtD
Etoposide—Paraesthesia—Prednisone—psoriatic arthritis	0.000189	0.001	CcSEcCtD
Etoposide—Pruritus—Triamcinolone—psoriatic arthritis	0.000188	0.001	CcSEcCtD
Etoposide—Cough—Methotrexate—psoriatic arthritis	0.000188	0.001	CcSEcCtD
Etoposide—Pruritus—Methylprednisolone—psoriatic arthritis	0.000188	0.001	CcSEcCtD
Etoposide—TOP2A—Methyltestosterone—Prednisolone—psoriatic arthritis	0.000187	0.034	CbGdCrCtD
Etoposide—Convulsion—Methotrexate—psoriatic arthritis	0.000186	0.000993	CcSEcCtD
Etoposide—Chest pain—Methotrexate—psoriatic arthritis	0.000183	0.000976	CcSEcCtD
Etoposide—Decreased appetite—Prednisone—psoriatic arthritis	0.000183	0.000973	CcSEcCtD
Etoposide—Rash—Prednisolone—psoriatic arthritis	0.000182	0.000971	CcSEcCtD
Etoposide—Dermatitis—Prednisolone—psoriatic arthritis	0.000182	0.00097	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000182	0.000969	CcSEcCtD
Etoposide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000181	0.000967	CcSEcCtD
Etoposide—Fatigue—Prednisone—psoriatic arthritis	0.000181	0.000965	CcSEcCtD
Etoposide—Headache—Prednisolone—psoriatic arthritis	0.000181	0.000965	CcSEcCtD
Etoposide—Discomfort—Methotrexate—psoriatic arthritis	0.000181	0.000964	CcSEcCtD
Etoposide—Constipation—Prednisone—psoriatic arthritis	0.00018	0.000957	CcSEcCtD
Etoposide—Confusional state—Methotrexate—psoriatic arthritis	0.000177	0.000943	CcSEcCtD
Etoposide—Dizziness—Triamcinolone—psoriatic arthritis	0.000176	0.000937	CcSEcCtD
Etoposide—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000175	0.000935	CcSEcCtD
Etoposide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000175	0.000934	CcSEcCtD
Etoposide—Infection—Methotrexate—psoriatic arthritis	0.000174	0.000929	CcSEcCtD
Etoposide—Feeling abnormal—Prednisone—psoriatic arthritis	0.000173	0.000922	CcSEcCtD
Etoposide—Asthenia—Betamethasone—psoriatic arthritis	0.000173	0.000922	CcSEcCtD
Etoposide—Asthenia—Dexamethasone—psoriatic arthritis	0.000173	0.000922	CcSEcCtD
Etoposide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000172	0.000916	CcSEcCtD
Etoposide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000172	0.000915	CcSEcCtD
Etoposide—Nausea—Prednisolone—psoriatic arthritis	0.000172	0.000915	CcSEcCtD
Etoposide—Pruritus—Betamethasone—psoriatic arthritis	0.000171	0.000909	CcSEcCtD
Etoposide—Pruritus—Dexamethasone—psoriatic arthritis	0.000171	0.000909	CcSEcCtD
Etoposide—Skin disorder—Methotrexate—psoriatic arthritis	0.00017	0.000908	CcSEcCtD
Etoposide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00017	0.000904	CcSEcCtD
Etoposide—Vomiting—Triamcinolone—psoriatic arthritis	0.000169	0.0009	CcSEcCtD
Etoposide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000169	0.000898	CcSEcCtD
Etoposide—Rash—Triamcinolone—psoriatic arthritis	0.000168	0.000893	CcSEcCtD
Etoposide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000167	0.000892	CcSEcCtD
Etoposide—Anorexia—Methotrexate—psoriatic arthritis	0.000167	0.000892	CcSEcCtD
Etoposide—Rash—Methylprednisolone—psoriatic arthritis	0.000167	0.000891	CcSEcCtD
Etoposide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000167	0.00089	CcSEcCtD
Etoposide—Urticaria—Prednisone—psoriatic arthritis	0.000167	0.000889	CcSEcCtD
Etoposide—Headache—Triamcinolone—psoriatic arthritis	0.000166	0.000887	CcSEcCtD
Etoposide—Headache—Methylprednisolone—psoriatic arthritis	0.000166	0.000885	CcSEcCtD
Etoposide—Abdominal pain—Prednisone—psoriatic arthritis	0.000166	0.000885	CcSEcCtD
Etoposide—Body temperature increased—Prednisone—psoriatic arthritis	0.000166	0.000885	CcSEcCtD
Etoposide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000165	0.000879	CcSEcCtD
Etoposide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000165	0.000879	CcSEcCtD
Etoposide—Hypotension—Methotrexate—psoriatic arthritis	0.000164	0.000874	CcSEcCtD
Etoposide—Dizziness—Dexamethasone—psoriatic arthritis	0.000159	0.00085	CcSEcCtD
Etoposide—Dizziness—Betamethasone—psoriatic arthritis	0.000159	0.00085	CcSEcCtD
Etoposide—Nausea—Triamcinolone—psoriatic arthritis	0.000158	0.000841	CcSEcCtD
Etoposide—Paraesthesia—Methotrexate—psoriatic arthritis	0.000158	0.00084	CcSEcCtD
Etoposide—Nausea—Methylprednisolone—psoriatic arthritis	0.000157	0.000839	CcSEcCtD
Etoposide—Dyspnoea—Methotrexate—psoriatic arthritis	0.000156	0.000834	CcSEcCtD
Etoposide—Somnolence—Methotrexate—psoriatic arthritis	0.000156	0.000831	CcSEcCtD
Etoposide—Hypersensitivity—Prednisone—psoriatic arthritis	0.000155	0.000825	CcSEcCtD
Etoposide—Vomiting—Betamethasone—psoriatic arthritis	0.000153	0.000817	CcSEcCtD
Etoposide—Vomiting—Dexamethasone—psoriatic arthritis	0.000153	0.000817	CcSEcCtD
Etoposide—Decreased appetite—Methotrexate—psoriatic arthritis	0.000153	0.000813	CcSEcCtD
Etoposide—Rash—Dexamethasone—psoriatic arthritis	0.000152	0.00081	CcSEcCtD
Etoposide—Rash—Betamethasone—psoriatic arthritis	0.000152	0.00081	CcSEcCtD
Etoposide—Dermatitis—Betamethasone—psoriatic arthritis	0.000152	0.00081	CcSEcCtD
Etoposide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000152	0.00081	CcSEcCtD
Etoposide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000151	0.000807	CcSEcCtD
Etoposide—Fatigue—Methotrexate—psoriatic arthritis	0.000151	0.000806	CcSEcCtD
Etoposide—Headache—Betamethasone—psoriatic arthritis	0.000151	0.000805	CcSEcCtD
Etoposide—Headache—Dexamethasone—psoriatic arthritis	0.000151	0.000805	CcSEcCtD
Etoposide—Asthenia—Prednisone—psoriatic arthritis	0.000151	0.000803	CcSEcCtD
Etoposide—Pain—Methotrexate—psoriatic arthritis	0.00015	0.0008	CcSEcCtD
Etoposide—Pruritus—Prednisone—psoriatic arthritis	0.000149	0.000792	CcSEcCtD
Etoposide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000145	0.000771	CcSEcCtD
Etoposide—Diarrhoea—Prednisone—psoriatic arthritis	0.000144	0.000766	CcSEcCtD
Etoposide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000143	0.000765	CcSEcCtD
Etoposide—Nausea—Betamethasone—psoriatic arthritis	0.000143	0.000763	CcSEcCtD
Etoposide—Nausea—Dexamethasone—psoriatic arthritis	0.000143	0.000763	CcSEcCtD
Etoposide—Urticaria—Methotrexate—psoriatic arthritis	0.000139	0.000743	CcSEcCtD
Etoposide—Dizziness—Prednisone—psoriatic arthritis	0.000139	0.00074	CcSEcCtD
Etoposide—Abdominal pain—Methotrexate—psoriatic arthritis	0.000139	0.000739	CcSEcCtD
Etoposide—Body temperature increased—Methotrexate—psoriatic arthritis	0.000139	0.000739	CcSEcCtD
Etoposide—Vomiting—Prednisone—psoriatic arthritis	0.000133	0.000712	CcSEcCtD
Etoposide—Rash—Prednisone—psoriatic arthritis	0.000132	0.000706	CcSEcCtD
Etoposide—Dermatitis—Prednisone—psoriatic arthritis	0.000132	0.000705	CcSEcCtD
Etoposide—Headache—Prednisone—psoriatic arthritis	0.000132	0.000701	CcSEcCtD
Etoposide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000129	0.000689	CcSEcCtD
Etoposide—Asthenia—Methotrexate—psoriatic arthritis	0.000126	0.000671	CcSEcCtD
Etoposide—Nausea—Prednisone—psoriatic arthritis	0.000125	0.000665	CcSEcCtD
Etoposide—Pruritus—Methotrexate—psoriatic arthritis	0.000124	0.000662	CcSEcCtD
Etoposide—Diarrhoea—Methotrexate—psoriatic arthritis	0.00012	0.00064	CcSEcCtD
Etoposide—Dizziness—Methotrexate—psoriatic arthritis	0.000116	0.000618	CcSEcCtD
Etoposide—Vomiting—Methotrexate—psoriatic arthritis	0.000112	0.000595	CcSEcCtD
Etoposide—Rash—Methotrexate—psoriatic arthritis	0.000111	0.00059	CcSEcCtD
Etoposide—Dermatitis—Methotrexate—psoriatic arthritis	0.000111	0.000589	CcSEcCtD
Etoposide—Headache—Methotrexate—psoriatic arthritis	0.00011	0.000586	CcSEcCtD
Etoposide—Nausea—Methotrexate—psoriatic arthritis	0.000104	0.000556	CcSEcCtD
